Investor Presentaiton
Innovative Partnership Examples
Partnership strategy is increasingly essential to extend our science and technology base
Valo
✓ DECIPHEX
QPathoQuest
-
I
-
I
|
Partnership established 2022
Al-enabled drug discovery
solutions
TM
Partnering on Logica ™, an Al-
powered drug solution that
leverages Valo Health's Opal
Computational Platform and
CRL's leading preclinical
expertise
■
Logica TM has the capability to
transform a drug target into a
first-in-class development
candidate in just over 2 years
-
Partnership established 2020
- Digital pathology
- Co-development of a digital
pathology workflow
First to offer clients GLP-
validated digital pathology peer
review using Deciphex Patholytix
Preclinical for toxicologic
pathology
Patholytix
Preclinical
- CRL is co-developing exclusive Al
models to support accelerate
pathology review
Partnership established in 2016
(expanded 2020)
Next-generation sequencing
(NGS) for biologics QC testing
- PathoQuest provides a pioneering
NGS approach to biologics
characterization and release
testing
- Rapid, in vitro testing approach
for viral safety testing and genetic
characterization of cell lines
Charles River Laboratories (CRL)
21
24View entire presentation